In a transgenic mouse model that overexpressed CYP2J2 in cardiomyocytes, cardioprotective EETs were generated that protected against arrhythmia susceptibility in cardiac hypertrophy (Westphal et al. 2013). The gene discussed is CYP2J2; the disease is cardiac hypertrophy.